Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
The endothelial glycocalyx (EG) is essential for proper function of the endothelium and for vascular integrity, but its role in premature atherogenesis in rheumatoid arthritis (RA) has not been studied yet. EG impairment can play a role in pathogenesis of vascular disease, and one of its characteris...
Saved in:
| Main Authors: | Gia Deyab, Trine Marita Reine, Tram Thu Vuong, Trond Jenssen, Gunnbjørg Hjeltnes, Stefan Agewall, Knut Mikkelsen, Øystein Førre, Morten Wang Fagerland, Svein Olav Kolset, Ivana Hollan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253247&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
by: Samuel A Curran, et al.
Published: (2014-01-01) -
Is Syndecan-2 a Key Angiogenic Element?
by: Oriol Noguer, et al.
Published: (2009-01-01) -
Significance of the Syndecan-4-Transglutaminase-2 Interaction
by: Elisabetta Verderio, et al.
Published: (2010-01-01) -
Transmembrane DomainDependent Functional Oligomerization of Syndecans
by: Jae Youn Yi, et al.
Published: (2006-01-01) -
Increased levels of syndecan-3 are associated with childhood obesity
by: Diego Muñoz-Moreno, et al.
Published: (2025-08-01)